Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuraxis (NRXS) Total Liabilities (2022 - 2025)

Neuraxis (NRXS) has disclosed Total Liabilities for 4 consecutive years, with $3.0 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities rose 11.7% to $3.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.0 million through Dec 2025, up 11.7% year-over-year, with the annual reading at $3.0 million for FY2025, 11.7% up from the prior year.
  • Total Liabilities hit $3.0 million in Q4 2025 for Neuraxis, down from $3.5 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $11.5 million in Q2 2023 to a low of $1.9 million in Q4 2023.
  • Historically, Total Liabilities has averaged $4.6 million across 4 years, with a median of $3.5 million in 2022.
  • Biggest YoY gain for Total Liabilities was 230.41% in 2023; the steepest drop was 72.89% in 2023.
  • Year by year, Total Liabilities stood at $7.1 million in 2022, then crashed by 72.89% to $1.9 million in 2023, then skyrocketed by 40.63% to $2.7 million in 2024, then rose by 11.7% to $3.0 million in 2025.
  • Business Quant data shows Total Liabilities for NRXS at $3.0 million in Q4 2025, $3.5 million in Q3 2025, and $2.8 million in Q2 2025.